Clinical Trial Update: Inhaled Cannabis for Treatment of PTSD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing inhaled cannabis as a treatment for post-traumatic stress disorder is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Cannabis, inhaled (Cannabis)

Snippet

Sponsor: Multidisciplinary Association for Psychedelic Studies | Conditions: Post Traumatic Stress Disorder PTSD | Phase 2 | Status: NOT_YET_RECRUITING